153 results
Page 2 of 8
8-K
EX-99.1
8l32jm
20 Apr 23
Heron Therapeutics Announces Commercial Leadership Changes
9:10am
8-K
EX-99.1
lndnq01audij
3 Apr 23
Heron Therapeutics Announces New CEO and Board Chairman
9:10am
8-K
EX-99.1
dbs6nh8yk45k4iueag6f
29 Dec 22
Other Events
9:10am
8-K
EX-99.1
zejccoy50fpjw5z6p46e
8 Nov 22
Results of Operations and Financial Condition
4:10pm
424B5
5sp8bz2i5ws4wp
20 Oct 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
p5ln8hfxbro 49
19 Sep 22
Other Events
8:00am
8-K
EX-99.1
y3uqm 8o7hkkgnow5y
9 Aug 22
Results of Operations and Financial Condition
8:20am
8-K
EX-99.1
4yy86b35v 02
30 Jun 22
Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
8:40am
8-K
EX-99.1
lc34bd dhgsloyap48og
14 Jun 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
q84dg7sou9
9 May 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
so04c1lanb6rx7iudrn
25 Mar 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
tocqpw
17 Mar 22
Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain
8:45am